Ratings for Lazard (NYSE:LAZ) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 4 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $57.86, a high estimate of $65.00, and a low estimate of $51.00. This current average has increased by 4.88% from the previous average price target of $55.17.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Lazard is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Ryan Kenny | Morgan Stanley | Raises | Equal-Weight | $63.00 | $60.00 |
| Aidan Hall | Keefe, Bruyette & Woods | Raises | Outperform | $65.00 | $59.00 |
| Devin Ryan | JMP Securities | Raises | Market Outperform | $59.00 | $55.00 |
| Devin Ryan | JMP Securities | Raises | Market Outperform | $55.00 | $52.00 |
| Brennan Hawken | UBS | Raises | Neutral | $52.00 | $49.00 |
| Ryan Kenny | Morgan Stanley | Raises | Overweight | $60.00 | $56.00 |
| Michael Brown | Wells Fargo | Announces | Equal-Weight | $51.00 | - |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Lazard. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Lazard compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Lazard's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of Lazard's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Lazard analyst ratings.
Delving into Lazard's Background
Lazard has a storied history that can be traced back to 1848. The company's revenue is nearly equally split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily equities (over 80% of assets under management), has an international focus, and is geared toward institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
Understanding the Numbers: Lazard's Finances
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Lazard's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 49.05%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 13.3%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Lazard's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 19.46%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Lazard's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.25%, the company showcases efficient use of assets and strong financial health.
Debt Management: Lazard's debt-to-equity ratio is notably higher than the industry average. With a ratio of 3.8, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Understanding the Relevance of Analyst Ratings
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
